Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Tilray Brands, Inc. TLRY

Alternate Symbol(s):  T.TLRY

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company. The Company operates through four segments: Cannabis business, Distribution business, Beverage alcohol business and Wellness business. The Cannabis business segment is engaged in the production, distribution, sale, co-manufacturing, and advisory services of both medical and adult-use cannabis. The Distribution business segment is focused on the purchase and resale of pharmaceutical products to customers. The Beverage alcohol business segment is engaged in the production, marketing and sale of beverage and beverage alcohol products. The Wellness business segment includes hemp foods and hemp-based cannabidiol (CBD) consumer products. The Company offers a portfolio of adult-use brands and products and expands its portfolio to include new cannabis products and formats. Its brands include Good Supply, RIFF, Broken Coast, Solei, Canaca, HEXO, Redecan, Original Stash, Bake Sale, XMG, Mollo, and others.


NDAQ:TLRY - Post by User

Post by Ventura2020on Feb 10, 2024 11:56am
201 Views
Post# 35873798

Tilray Pharma Germany

Tilray Pharma Germany

Benefits of De-Listing Cannabis

A major provision of the new law involves cannabis being removed from Germany’s Narcotics List, which is extremely significant for multiple reasons. First, Germany’s medical cannabis program will greatly benefit from the nation’s adult-use legalization law via the de-listing of cannabis. Changing cannabis’ listing will also remove various hurdles and barriers related to Germany’s medical cannabis supply chain. It should lead to the rise of online prescriptions, which would streamline processes for pharmacies and allow them to mail medical cannabis directly to patients.

Cannabis research should be easier to conduct in Germany because of cannabis no longer being on the nation’s Narcotics List. German academic institutions may prove to be one of the largest financial beneficiaries of legalization via new national and/or European Union-provided funds for specific cannabis research projects.

A Powerful Step Forward

Germany won’t be the first nation to pass a national adult-use legalization measure. However, it’s going to be the largest prohibition domino to fall thus far, and it will open the floodgates to similar reforms in Europe and beyond. 

Germany’s influence within the international and continental communities is significant, and when it proves that sensible cannabis policy modernization works, other nations are expected to follow suit, particularly in the region where Germany is located. Germany shares more borders with other countries in Europe than any other nation, and the Czech Republic has already indicated that it will be pursuing similar reforms once Germany legalizes.

Germany is the most exciting place on earth for cannabis right now. This will be the first April in Germany with cannabis being legal since the start of prohibition, and that’s exciting by every measure. It also makes the International Cannabis Business Conference in Berlinon April 16-17 a must-attend. Join me and be a part of international cannabis history.
https://cannabisnow.com/german-cannabis-legalization-expected-in-april/amp/

<< Previous
Bullboard Posts
Next >>